Cirrhotic portal hypertension reversal mechanism and its therapy
10.3760/cma.j.cn501113-20220508-00247
- VernacularTitle:肝硬化门静脉高压逆转的机制及其治疗
- Author:
Changpeng ZHU
1
;
Weifen XIE
Author Information
1. 海军军医大学附属长征医院消化内科，上海 200003
- Keywords:
Liver cirrhosis;
Portal hypertension;
Liver sinusoidal endothelial cells;
Microvascular thrombosis;
Angiogenesis;
Gut-liver axis
- From:
Chinese Journal of Hepatology
2022;30(6):572-576
- CountryChina
- Language:Chinese
-
Abstract:
Portal hypertension is one of the most serious complications in patients with liver cirrhosis, and its prevention and treatment are essential to improve patient outcomes. The main pathophysiological basis of cirrhotic portal hypertension is increased intrahepatic vascular resistance and/or increased portal blood flow. In recent years, studies have suggested that liver sinusoid endothelial cells dysfunction, hepatic microvascular thrombosis, pathological angiogenesis, and gut-liver axis imbalance play critical roles in the development of portal hypertension. With respect to this, targeted therapy drugs have made significant advances. This article discusses the cirrhotic portal hypertension reversal mechanism and the current status of its treatment.
